Literature DB >> 993351

The role of insulin and glucagon in the regulation of basal glucose production in the postabsorptive dog.

A D Cherrington, J L Chiasson, J E Liljenquist, A S Jennings, U Keller, W W Lacy.   

Abstract

The aim of the present experiments was to determine the role of insulin and glucagon in the regulation of basal glucose production in dogs fasted overnight. A deficiency of either or both pancreatic hormones was achieved by infusin somatostatin (1 mug/kg per min), a potent inhibitor of both insulin and glucagon secretion, alone or in combination with intraportal replacement infusions of either pancreatic hormone. Infusion of somatostatin alone caused the arterial levels of insulin and glucagon to drop rapidly by 72+/-6 and 81+/-8%, respectively. Intraportal infusion of insulin and glucagon at rates of 400 muU/kg per min and 1 ng/kg per min, respectively, resulted in the maintenance of the basal levels of each hormone. Glucose production was measured using tracer (primed constant infusion of [3-3H]glucose) and arteriovenous difference techniques. Isolated glucagon deficiency resulted in a 35+/-5% (P less than 0.05) rapid and sustained decrease in glucose production which was abolished upon restoration of the plasma glucagon level. Isolated insulin deficiency resulted in a 52+/-16% (P less than 0.01) increase in the rate of glucose production which was abolished when the insulin level was restored. Somatostatin had no effect on glucose production when the changes in the pancreatic hormone levels which it normally induces were prevented by simultaneous intraportal infusion of both insulin and glucagon. In conclusion, in the anesthetized dog fasted overnight; (a) basal glucagon is responsible for at least one-third of basal glucose production, (b) basal insulin prevents the increased glucose production which would result from the unrestrained action of glucagon, and (c) somatostatin has no acute effects on glucose turnover other than those it induces through perturbation of pancreatic hormone secretion. This study indicates that the opposing actions of the two pancreatic hormones are important in the regulation of basal glucose production in the postabsorptive state.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 993351      PMCID: PMC333312          DOI: 10.1172/JCI108596

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  54 in total

1.  Does somatostatin inhibition of insulin secretion involve two mechanisms of action?

Authors:  D L Curry; L L Bennett
Journal:  Proc Natl Acad Sci U S A       Date:  1976-01       Impact factor: 11.205

2.  Studies on the inhibition of insulin release, glycogenolysis and gluconeogenesis by somatostatin in the rat islets of langerhans and isolated hepatocytes.

Authors:  J R Oliver; S R Wagle
Journal:  Biochem Biophys Res Commun       Date:  1975-02-03       Impact factor: 3.575

3.  Heterogeneity of plasma glucagon immunoreactivity in normal, depancreatized, and alloxan-diabetic dogs.

Authors:  I Valverde; R Dobbs; R H Unger
Journal:  Metabolism       Date:  1975-09       Impact factor: 8.694

4.  Comparison of cylic and linear forms of somatostatin in the inhibiton of growth hormone, insulin and glucagon Secretion.

Authors:  H Leblanc; S S Yen
Journal:  J Clin Endocrinol Metab       Date:  1975-05       Impact factor: 5.958

5.  High molecular weight glucagon-like immunoreactivity in plasma.

Authors:  G C Weir; S D Knowlton; D B Martin
Journal:  J Clin Endocrinol Metab       Date:  1975-02       Impact factor: 5.958

6.  Gluconeogenesis from alanine in normal postabsorptive man. Intrahepatic stimulatory effect of glucagon.

Authors:  J L Chiasson; J E Liljenquist; B C Sinclair-Smith; W W Lacy
Journal:  Diabetes       Date:  1975-06       Impact factor: 9.461

7.  Estimation of pancreatic IRI output rate and its relations to glucose tolerance in normal anasthetized dogs.

Authors:  U Fischer; H Hommel; P Heinke; E Jutzi
Journal:  Diabetologia       Date:  1975-08       Impact factor: 10.122

8.  Persistent pancreatic glucagon but not insulin response to arginine in pancreatectomized dogs.

Authors:  K Mashiter; P E Harding; M Chou; G D Mashiter; J Stout; D Diamond; J B Field
Journal:  Endocrinology       Date:  1975-03       Impact factor: 4.736

9.  Evidence for a physiologic role of pancreatic glucagon in human glucose homeostasis: studies with somatostatin.

Authors:  J E Gerich; M Lorenzi; S Hane; G Gustafson; R Guillemin; P H Forsham
Journal:  Metabolism       Date:  1975-02       Impact factor: 8.694

10.  The role of glucagon in the pathogenesis of the endogenous hyperglycemia of diabetes mellitus.

Authors:  H Sakurai; R E Dobbs; R H Unger
Journal:  Metabolism       Date:  1975-11       Impact factor: 8.694

View more
  55 in total

1.  Effects of long-term cranberry supplementation on endocrine pancreas in aging rats.

Authors:  Min Zhu; Jingping Hu; Evelyn Perez; Dawn Phillips; Wook Kim; Reza Ghaedian; Joshua K Napora; Sige Zou
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-07-18       Impact factor: 6.053

2.  Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans.

Authors:  K F Petersen; D Laurent; D L Rothman; G W Cline; G I Shulman
Journal:  J Clin Invest       Date:  1998-03-15       Impact factor: 14.808

3.  Morphological and biochemical observations on hepatic glycogen metabolism in mice on a controlled feeding schedule. I. Normal mice.

Authors:  E S Hammad; J S Striffler; R R Cardell
Journal:  Dig Dis Sci       Date:  1982-08       Impact factor: 3.199

4.  Effect of glucagon antibodies on plasma glucose, insulin and somatostatin in the fasting and fed rat.

Authors:  K Tan; D Tsiolakis; V Marks
Journal:  Diabetologia       Date:  1985-07       Impact factor: 10.122

5.  Differential effects of insulin on splanchnic and peripheral glucose disposal after an intravenous glucose load in man.

Authors:  L Saccà; M Cicala; B Trimarco; B Ungaro; C Vigorito
Journal:  J Clin Invest       Date:  1982-07       Impact factor: 14.808

6.  Evaluation of insulin secretion after pancreas autotransplantation by oral or intravenous glucose challenge.

Authors:  P Calhoun; K S Brown; D A Krusch; E Barido; A H Farris; W G Schenk; L E Rudolf; D K Andersen; J B Hanks
Journal:  Ann Surg       Date:  1986-11       Impact factor: 12.969

7.  Alterations in alanine metabolism in diabetic dogs during short-term treatment with an artificial B cell.

Authors:  E J Freyse; U Fischer; G Albrecht; E Salzsieder
Journal:  Diabetologia       Date:  1985-10       Impact factor: 10.122

8.  Glucagon sensitivity and clearance in type 1 diabetes: insights from in vivo and in silico experiments.

Authors:  Ling Hinshaw; Ashwini Mallad; Chiara Dalla Man; Rita Basu; Claudio Cobelli; Rickey E Carter; Yogish C Kudva; Ananda Basu
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-07-07       Impact factor: 4.310

9.  Comparison of the effects of recombinant human insulin-like growth factor-I and insulin on glucose and leucine kinetics in humans.

Authors:  R Laager; R Ninnis; U Keller
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

10.  Neutralization of glucagon by antiserum as a tool in glucagon physiology. Lack of depression of basal blood glucose after antiserum treatment in rats.

Authors:  J J Holst; H Galbo; E A Richter
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.